Calendar
event
Ex dividend date
03 Jun 2024
event_available
Last Dividend Payment
01 Jan 1970
About Boiron SA
Ticker
info
BOI
Trading on
info
PA
ISIN
info
FR0000061129
Industry
info
Drug Manufacturers - Specialty & Generic
Sector
info
Healthcare
CEO
info
-
Headquarters
info
2, avenue de l’Ouest Lyonnais, Messimy, undefined, France, 69510
Employees
info
2,788
Website
info
boiron.fr
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sédatif PC to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain. In addition, it offers Dermoplasmine, a plant based multi-use balm that repairs and protects irritated and damaged skin; COVID self-tests and rapid antigenic tests; LABIAMEO, that used to treat outbreaks of localized cold sores; and CONVAMEO to treat physical and mental asthenia. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
Metrics
BasicAdvanced
Market cap
info
€417M
P/E ratio
info
17.65
EPS
info
€1.36
Dividend Yield
info
5.64%
Beta
info
0.42
Forward P/E ratio
info
15.55
EBIDTA
info
€64.5M
Ex dividend date
info
2024-06-03
Price & volume
Market cap
info
€417M
Average daily volume
info
0M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
€1.35
Dividend yield
info
5.64%
Forward dividend per share
info
€1.35
Forward dividend yield
info
5.64%
Payout ratio
info
99.26%
Valuation
P/E ratio
info
17.65
Forward P/E
info
15.55
PEG ratio
info
0
Trailing P/E
info
17.65
Price to sales
info
0.87
Price to book
info
1.12
Earnings
EPS
info
€1.36
EPS estimate (current quarter)
info
€0.00
EPS estimate (next quarter)
info
€0.00
EBITDA
info
€64.5M
Revenues (TTM)
info
€482M
Revenues per share (TTM)
info
€27.75
Technicals
Beta
info
0.42
52-week High
info
€36.35
52-week Low
info
€22.90
50-day moving average
info
€25.20
200-day moving average
info
€29.55
Short ratio
info
0
Short %
info
0.00%
Management effectiveness
ROE (TTM)
info
4.85%
ROA (TTM)
info
4.41%
Profit margin
info
4.92%
Gross profit margin
info
€351M
Operating margin
info
5.98%
Growth
Quarterly earnings growth (YoY)
info
78.50%
Quarterly revenue growth (YoY)
info
4.80%
Share stats
Outstanding Shares
info
17.4M
Float
info
4.1M
Insiders %
info
86.04%
Institutions %
info
6.01%
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-
-
-
Q4 • 13Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
€253M
€20.4M
8.04%
Q4 • 23
€228M
€3.3M
1.46%
Q2 • 24
9.87%
83.63%
81.84%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
€590M
€199M
33.67%
Q4 • 23
€558M
€185M
33.12%
Q2 • 24
5.51%
7.06%
1.63%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
€29.1M
-
€-179M
€23.5M
Q4 • 23
€13.5M
-
€-27.4M
€9.5M
Q2 • 24
53.49%
-
84.68%
59.33%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Boiron SA share?
Collapse

Boiron SA shares are currently traded for undefined per share.

How many shares does Boiron SA have?
Collapse

Boiron SA currently has 17.4M shares.

Does Boiron SA pay dividends?
Collapse

Yes, Boiron SA does pay dividends.

What is Boiron SA 52 week high?
Collapse

Boiron SA 52 week high is €36.35.

What is Boiron SA 52 week low?
Collapse

Boiron SA 52 week low is €22.90.

What is the 200-day moving average of Boiron SA?
Collapse

Boiron SA 200-day moving average is €29.55.

Who is Boiron SA CEO?
Collapse

The CEO of Boiron SA is -.

How many employees Boiron SA has?
Collapse

Boiron SA has 2,788 employees.

What is the market cap of Boiron SA?
Collapse

The market cap of Boiron SA is €417M.

What is the P/E of Boiron SA?
Collapse

The current P/E of Boiron SA is 17.65.

What is the EPS of Boiron SA?
Collapse

The EPS of Boiron SA is €1.36.

What is the PEG Ratio of Boiron SA?
Collapse

The PEG Ratio of Boiron SA is 0.